| Revenue growth | 33.2% YoY Consolidated growth. |
|---|---|
| Margins | Consolidated EBITDA margins stable at 19.9% vs 19.6% YoY. |
| Demand visibility | Strong; patient volumes and surgical activity increasing. |
| Management confidence | High; expanding regional presence beyond Dhanbad. |
Growth
Revenue up 33.2%, EBITDA up 35.3%, and PAT up 36.7% YoY on a consolidated basis.
Outlook
Focusing on migrating to the Main Board, expanding referral networks, and enhancing specialized cancer care infrastructure.
Risks
Surgical Oncology revenue declined 53% due to lower complex surgery volumes and case realizations.
Last quarter's promises, checked
Delivered
- Guided FY27 Revenue ₹260 Cr → Current Q1 ₹47.5 Cr (= BEAT)
- Guided EBITDA Margin 23-25% → Q1 19.9% (= PARTIAL)
- Guided Main Board Migration after July → Initiated process (= BEAT)
Partly delivered
- Guided Bed Capacity 500+ by 2028 → Added 50 beds in Ranguni (= PARTIAL)
Missed
- Guided Bone Marrow Facility live FY26 → Still pending approval (= MISS)
- Guided Cancer Unit occupancy growth → Surgical Oncology revenue fell 53% (= MISS)
Investor Presentation filed with BSE, BSE: 543943. Summary written with AI assistance from the document.
Asarfi Hospital Ltd: key numbers
- Share price
- ₹195.30
- Market cap
- ₹384.3 Cr
- Revenue (annual)
- ₹173.5 Cr
- Net profit (annual)
- ₹16.66 Cr
- P/E (TTM)
- 23.1×Sector 34.2×
- Promoter holding
- 61.17%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Asarfi Hospital Ltd
All →Asarfi Hospital Annual General Meeting
Asarfi Hospital Ltd's 21st Annual General Meeting held on September 18, 2026, saw shareholder approval for financial statements, director reappointment, and migration to the BSE Main Board.
Asarfi Hospital Annual Report
Asarfi Hospital Limited has submitted its Annual Report for the Financial Year 2025-26 in compliance with SEBI Listing Regulations.
Asarfi Hospital Other Announcement
Asarfi Hospital Limited has appointed M/s Ashutosh Kumar Sinha & Co as the Cost Auditor for the financial year 2026-27, as approved by the Board.
Asarfi Hospital Board Meeting Outcome
Asarfi Hospital approved its 21st AGM, appointment of auditors, and migration from BSE SME to the BSE Main Board and NSE.
Asarfi Hospital Board Meeting Date
Asarfi Hospital Ltd has scheduled a board meeting for August 25, 2026, to discuss the AGM and proposed migration to the BSE Main Board.
Asarfi Hospital Q1 FY27 Results: Net Profit ₹4.3 Cr, Up 38.7% YoY
Asarfi Hospital Ltd reported revenue from operations of ₹47.5 Cr (+33.1% YoY) and net profit of ₹4.3 Cr (+38.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹4.3 Cr · +38.7% YoY